老板办公室乳摸GIF动态图,色婷婷亚洲一区二区三区,国产全是老熟女太爽了,欧美极度残忍变态另类电影
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2023.04.19
Notification Letter and Request Form to Non-Registered Shareholders
2023.04.19
2022 AGM Circular
2023.04.19
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2023.04.19
ANNUAL REPORT 2022
2023.04.17
DATE OF BOARD MEETING
2023.04.04
VOLUNTARY ANNOUNCEMENT ENTERING INTO DISTRIBUTION AND SUPPLY AGREEMENT WITH CTTQ...
2023.03.30
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022
2023.03.28
VOLUNTARY ANNOUNCEMENT ENTERING INTO LICENSE AND DISTRIBUTION AGREEMENT WITH OEP...
2023.03.17
VOLUNTARY ANNOUNCEMENT “ENOXAPARIN SODIUM INJECTION” OBTAINED ANDA APPROVAL FROM...
2023.03.15
DATE OF BOARD MEETING
第一頁
上一頁
5
6
7
8
9
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
